Literature DB >> 15280048

Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector.

C Bruce A Whitelaw1, Pippa A Radcliffe, William A Ritchie, Ailsa Carlisle, Fiona M Ellard, Romi N Pena, Jo Rowe, A John Clark, Tim J King, Kyriacos A Mitrophanous.   

Abstract

Traditional methods of transgene delivery in livestock are inefficient. Recently, human immunodeficiency virus (HIV-1) based lentiviral vectors have been shown to offer an efficient transgene delivery system. We now extend this method by demonstrating efficient generation of transgenic pigs using an equine infectious anaemia virus derived vector. We used this vector to deliver a green fluorescent protein expressing transgene; 31% of injected/transferred eggs resulted in a transgenic founder animal and 95% of founder animals displayed green fluorescence. This compares favourably with results using HIV-1 based vectors, and is substantially more efficient than the standard pronuclear microinjection method, indicating that lentiviral transgene delivery may be a general tool with which to efficiently generate transgenic mammals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280048     DOI: 10.1016/j.febslet.2004.06.076

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

1.  Welfare assessment in transgenic pigs expressing green fluorescent protein (GFP).

Authors:  Reinhard C Huber; Liliana Remuge; Ailsa Carlisle; Simon Lillico; Peter Sandøe; Dorte B Sørensen; C Bruce A Whitelaw; I Anna S Olsson
Journal:  Transgenic Res       Date:  2011-12-16       Impact factor: 2.788

2.  A new method to efficiently produce transgenic embryos and mice from low-titer lentiviral vectors.

Authors:  Kai Miao; Min Guo; Lei An; Xiao Ling Xu; Han Wu; Dong Wang; Zhong Hong Wu; Jian Hui Tian
Journal:  Transgenic Res       Date:  2010-06-29       Impact factor: 2.788

Review 3.  Transgenic pigs as models for translational biomedical research.

Authors:  Bernhard Aigner; Simone Renner; Barbara Kessler; Nikolai Klymiuk; Mayuko Kurome; Annegret Wünsch; Eckhard Wolf
Journal:  J Mol Med (Berl)       Date:  2010-03-26       Impact factor: 4.599

4.  CMV enhancer-promoter is preferentially active in exocrine cells in vivo.

Authors:  D B Vasey; S G Lillico; H M Sang; T J King; C B A Whitelaw
Journal:  Transgenic Res       Date:  2008-12-16       Impact factor: 2.788

Review 5.  Animal pharming, two decades on.

Authors:  Alexander Kind; Angelika Schnieke
Journal:  Transgenic Res       Date:  2008-07-29       Impact factor: 2.788

6.  Skin-specifically transgenic expression of biologically active human cytoxic T-lymphocyte associated antigen4-immunoglobulin (hCTLA4Ig) in mice using lentiviral vector.

Authors:  Wen Jiang; Xiao-Yang Zhou; Lu-lu Wang; Qin Liu; Cang'e Liu; Yong Wang; Hong Wei
Journal:  Transgenic Res       Date:  2011-10-08       Impact factor: 2.788

7.  Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.

Authors:  Alexander Pfeifer; Sabina Eigenbrod; Saba Al-Khadra; Andreas Hofmann; Gerda Mitteregger; Markus Moser; Uwe Bertsch; Hans Kretzschmar
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

8.  Engineering Large Animal Species to Model Human Diseases.

Authors:  Christopher S Rogers
Journal:  Curr Protoc Hum Genet       Date:  2016-07-01

9.  Quantitative analysis of lentiviral transgene expression in mice over seven generations.

Authors:  Yong Wang; Yong-tao Song; Qin Liu; Cang'e Liu; Lu-lu Wang; Yu Liu; Xiao-yang Zhou; Jun Wu; Hong Wei
Journal:  Transgenic Res       Date:  2010-01-22       Impact factor: 2.788

10.  Generation of domestic transgenic cloned kittens using lentivirus vectors.

Authors:  Martha C Gómez; Charles Earle Pope; Robert H Kutner; David M Ricks; Leslie A Lyons; Mark T Ruhe; Cherie Dumas; Justine Lyons; Betsy L Dresser; Jakob Reiser
Journal:  Cloning Stem Cells       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.